Spero Therapeutics
Clinical trials sponsored by Spero Therapeutics, explained in plain language.
-
New hope for stubborn lung infection: experimental drug shows promise
Disease control CompletedThis study tested an experimental drug called SPR720 in 25 adults with a chronic lung infection caused by Mycobacterium avium complex (MAC). The goal was to see if the drug can reduce bacteria in sputum and improve symptoms compared to a placebo. Participants took the drug or pla…
Phase: PHASE2 • Sponsor: Spero Therapeutics • Aim: Disease control
Last updated May 22, 2026 13:50 UTC
-
Could a pill replace IV antibiotics for tough UTIs?
Disease control CompletedThis study tested an oral antibiotic called tebipenem against a standard IV antibiotic in 1,690 hospitalized adults with complicated urinary tract infections or acute kidney infections. The goal was to see if the oral drug works as well as the IV drug at curing the infection and …
Phase: PHASE3 • Sponsor: Spero Therapeutics • Aim: Disease control
Last updated May 18, 2026 12:03 UTC